We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Exploring the potential benefits and current evidence for acupuncture in managing age-related macular degeneration (AMD). Learn about TCM and scientific perspectives, safety, and when to consult a doctor.

Macular degeneration, clinically known as age-related macular degeneration (AMD), is a common eye condition that affects millions of people, particularly as they age. It impacts the macula, a small part of the retina responsible for sharp, central vision, which is crucial for activities like reading, driving, and recognizing faces. While AMD doesn't cause complete blindness, it can significantly impair vision, leading to a loss of central vision. This condition can manifest in two forms: dry AMD, which is more common and progresses slowly, and wet AMD, which is less common but can cause rapid, severe vision loss.
For centuries, Traditional Chinese Medicine (TCM) has utilized acupuncture as a therapeutic practice. Acupuncture involves the precise insertion of very fine needles into specific points on the body. The goal is to stimulate these points, aiming to influence the body's energy flow (known as 'qi') and promote healing. While acupuncture is widely recognized for its effectiveness in pain management, a growing interest has emerged in its potential application for various other health conditions, including eye disorders like macular degeneration.
The question of whether acupuncture can effectively treat macular degeneration is complex and currently lacks a definitive answer. Some research suggests that acupuncture may offer benefits for individuals with AMD. A review conducted in 2023 indicated that acupuncture might improve certain aspects of AMD, such as central macular thickness. However, the quality of the evidence supporting these findings was rated as 'low' to 'very low.' Out of 226 studies examined, only nine met the criteria for inclusion in this review, highlighting the limited robust research available.
Another review from 2022 exploring Traditional Chinese Medicine (TCM) for AMD concluded that these approaches show promise. Nevertheless, the review emphasized that the lack of strong scientific evidence behind these practices restricts their widespread adoption. A 2020 overview also noted that existing biases in current research studies prevent the definitive confirmation of acupuncture's validity for treating eye disorders.
While some studies suggest potential benefits, a broad consensus among medical professionals has not yet been reached. More high-quality, large-scale studies are essential to confirm the effectiveness of acupuncture as a treatment for macular degeneration.
The proposed mechanisms by which acupuncture might benefit macular degeneration are explained through both TCM theory and scientific hypotheses.
In TCM, diseases are often viewed as a result of imbalances in the body's vital energy, 'qi,' and disruptions in the flow of blood. For eye conditions like AMD, TCM theory suggests that acupuncture aims to restore the balance of 'qi' and improve blood circulation to the eyes. By stimulating specific acupuncture points, practitioners believe they can unblock energy pathways and enhance the nourishment of the macula, thereby potentially slowing disease progression and improving vision.
From a scientific standpoint, the exact mechanisms are still under investigation. However, several theories are being explored:
Micro acupuncture, also known as emayaoling acupuncture, is a more specialized form of acupuncture. It involves a more focused and intensive application of needles, often targeting specific points related to vision. A 2017 study found that emayaoling acupuncture produced better clinical outcomes in early AMD compared to traditional acupuncture. However, research on this specific approach is even more limited than on general acupuncture for AMD.
In a clinical setting, acupuncture is generally considered safe when performed by a qualified and licensed practitioner. The 2022 review on acupuncture for macular degeneration indicated no obvious side effects when used in a clinical context. However, like any invasive procedure, there are potential risks, although they are typically minor.
The most commonly reported acupuncture-related reactions include:
Some practitioners argue that these responses, such as slight bleeding or a ']})*&'flare-up' of symptoms, can be intended reactions that indicate the treatment is working. It is crucial to discuss any concerns about safety and potential side effects with your acupuncturist.
Despite the emerging research, several limitations need to be addressed:
Future research should focus on high-quality studies that can provide conclusive evidence regarding acupuncture's role in managing macular degeneration.
If you are experiencing any changes in your vision, such as blurred vision, distorted straight lines, or a dark spot in your central vision, it is crucial to consult an eye care professional immediately. Early diagnosis and treatment are key to managing macular degeneration and preserving vision.
If you are considering acupuncture as a complementary therapy for macular degeneration, it is essential to discuss this with your ophthalmologist. They can provide guidance on whether it might be appropriate for your specific condition and advise on potential interactions with conventional treatments. Always ensure that any acupuncture treatment is performed by a licensed and experienced practitioner.
Explore the ancient uses and potential benefits of spikenard essential oil, from aromatherapy to its anti-inflammatory properties, with safety tips for Indian readers.
April 1, 2026
Explore the world of herbal tinctures: what they are, how they're made, their benefits, and crucial safety tips for use in India. Learn from nature's potent extracts.
April 1, 2026

Discover the ancient secrets of pearl powder for radiant skin and enhanced health. Learn about its benefits, how it's made, and how to use it.
April 1, 2026